Elicera Therapeutics AB banner

Wall St Price Targets

ELIC Price Forecast
Based on 4 analysts

+159% Upside
from kr2.85 today

Elicera Therapeutics AB (ELIC)’s 12-month stock price forecast through October 2027 has a consensus target of kr7.4, implying 159% upside. The forecast is based on price targets from 4 Wall Street analysts.

ELIC Analyst Rating
No ratings yet

No rating

We don't have analyst ratings for ELIC yet.

Elicera Therapeutics AB Competitors:
Price Targets

Financial forecasts

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Value YoY Lowest–highest Analysts
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is ELIC's stock price target?
Price Target
7.4 SEK

According to Wall Street analysts, the average 1-year price target for ELIC is 7.4 SEK with a low forecast of 6.57 SEK and a high forecast of 8.4 SEK.

What is the Revenue forecast for Elicera Therapeutics AB?
Projected CAGR
96%

Over the last 4 years, the compound annual growth rate for Revenue has been 1 060%. The projected CAGR for the next 3 years is 96%.

Back to Top